-
AIDS Dialogue | Breakthroughs in HIV Treatment: In-Depth Discussion on Integrase Inhibitors, Weight Management, and Prevention Strategies
With continuous advancements in technology and deepening research in the field of AIDS prevention, new breakthroughs in HIV treatment and management have emerged. During the 25th International AIDS Conference, “Infectious Diseases Frontier” invited Dr. Hui Wang from Shenzhen Third People’s Hospital and Dr. Huachun Zou from the Fudan University School of Public Health for an in-depth dialogue. They shared the…
-
SIFIC: Leading with Wisdom, Embracing Openness and Innovation
Recently, the 20th Shanghai International Forum for Infection Control (SIFIC) and the 8th Oriental Forum on Complex Infectious Diseases (OFCID), along with the Annual Academic Meeting of the Global Chinese Clinical Microbiology and Infectious Diseases Society, were successfully held in Shanghai. Infectious Diseases Frontier had the privilege of interviewing several administrators of the SIFIC forum…
-
Dr. Davide Rossi: The Role of Liquid Biopsy (ctDNA) in the Diagnosis and Treatment of Malignant Lymphoma
In the field of lymphoma diagnosis and treatment, traditional methods such as tissue biopsy, while valuable, are increasingly showing limitations due to their invasive nature, inconvenience in repeated sampling, and inability to fully reflect tumor heterogeneity. Liquid biopsy, as an emerging non-invasive testing technology, is demonstrating great potential in the diagnosis and treatment of lymphoma.…
-
Dr. Owen O’Connor: The Vessel of Hope for Peripheral T-Cell Lymphoma Braves the Storm and Forges Ahead Fearlessly | The 8th Hematologic Oncology
In order to further improve the diagnostic and treatment level of leukemia and lymphoma in China, “The 8th Hematologic Oncology Academic Conference of CSCO,” co-hosted by the Chinese Society of Clinical Oncology (CSCO), the Leukemia Expert Committee of CSCO, and the Lymphoma Expert Committee, and co-organized by the Harbin Hematological Tumor Research Institute and Peking…
-
EHA Global Perspectives | Dr. Edward Laane: Advancing Breakthroughs in MM Treatment and PRO Standardization
Multiple myeloma (MM) has long been a focus of hematology research due to its complex nature and the challenges it presents in treatment. As treatment methods continue to advance and new drugs emerge, patient survival rates and quality of life are receiving unprecedented attention. In this context, the accurate measurement of patient-reported outcomes (PROs) becomes…
-
Dr. Dong Ji: Exploring Liver Fibrosis Reversal and Personalized Treatment
The liver is a powerful organ with complex physiological structures and functions. Liver fibrosis is a dynamic pathological process associated with various chronic liver diseases, ultimately leading to cirrhosis. In cirrhosis, the liver not only becomes harder but also shrinks in size, with imaging showing changes in the liver’s appearance accompanied by alterations in hepatic…
-
Dr. Hui Wang: PURPOSE 1 Study Reveals Outstanding Efficacy of Long-Acting Injectable Lenacapavir in Preventing HIV Infection in Women
On July 24th, during the highly anticipated Co-Chairs’ Choice session at the 25th International AIDS Conference in Munich, Germany, the PURPOSE 1 study was unveiled, highlighting a significant breakthrough in HIV prevention. The study demonstrated the exceptional efficacy of the long-acting injectable drug Lenacapavir in preventing HIV infection among women. The study was simultaneously published…
-
SIFIC 2024 | Dr. Fan Wu: Challenges and Control of Candida auris and Babesiosis
The 20th Shanghai International Forum for Infection Control (SIFIC) and the 8th Oriental Forum on Complex Infectious Diseases (OFCID), jointly held with the Global Chinese Society of Clinical Microbiology and Infectious Diseases (GCSCMID) Annual Meeting, successfully took place at the Shanghai International Convention Center from July 25-27, 2024. During the event, Dr. Fan Wu from…
Connecting Medical Expertise through Media